| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |